Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals Gallery

Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals

Vivo Capital’s Portfolio Company IO Biotech Announces an IPO Gallery

Vivo Capital’s Portfolio Company IO Biotech Announces an IPO

Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery

Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)

Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals Gallery

Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders Gallery

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

Serán Bioscience Announces Investment by Vivo Capital Gallery

Serán Bioscience Announces Investment by Vivo Capital

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China Gallery

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China